Skip to main content

Table 2 Primary and secondary outcomes

From: The use of tamsulosin in the treatment of 10–15 mm lower ureteral stones in adults: a double-blinded randomized controlled trial

Outcome

Tamsulosin group (N = 40)

Control group (N = 40)

p value

Primary outcome

   

 % Spontaneous ureteral stone passage

15

0

0.026

 % Adjusted spontaneous stone passage

10

0

0.12

Secondary outcomes

   

 %Total dose of on-demand oral diclofenac ≥ 100mga

72.5

65

0.3

 % No dilatation on ureteroscopy

14.7b

0

0.015

 % Stentless ureteroscopy

23.5b

12.5

0.2

 % Overall adverse effects related to drugs

37.5

30

0.7

  % Dizziness

25

22.5

0.9

  % Ejaculatory dysfunctionc

17.9

3.5

0.1

  1. aExcluding the 1st week of treatment
  2. bIn 34 pts who underwent ureteroscopy
  3. cAmong men in both groups